Biohaven (BHVN) announced a multi-target collaboration with Merus (MRUS). This collaboration will co-develop three programs encompassing highly differentiated next generation dual-targeted bispecific ADCs leveraging Biohaven’s proprietary conjugation and payload technologies along with Merus’ leading Biclonics technology platform.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BHVN: